
- An early evaluation from the continuing RESTORE trial suggests semaglutide might enhance fertility-related outcomes in females with polyendocrine metabolic ovarian syndrome (PMOS), previously generally known as PCOS.
- A evaluate additionally means that GLP-1 medication might help male reproductive well being in these with weight problems by bettering testosterone ranges, reproductive hormones, and sperm high quality whereas additionally bettering metabolic well being.
- The findings help the concept that treating weight problems and metabolic dysfunction with GLP-1 medication might assist restore hormonal stability and reproductive operate in each men and women. Nonetheless, bigger, longer-term research are vital to substantiate these results.
Thus, lifestyle changes, similar to adopting balanced dietary plans, partaking in common bodily exercise, and sustaining a wholesome weight, can assist improve reproductive outcomes and help fertility.
Now, rising analysis suggests these drugs might also have optimistic results on reproductive well being. Two research point out that GLP-1 medication might provide reproductive advantages, along with supporting weight reduction and metabolic well being.
Firstly, an evaluation printed in Fertility and Sterility discovered potential enhancements in fertility-related outcomes amongst ladies with PMOS.
Secondly, a review of clinical trials introduced at ENDO 2026 — which is but to seem in a peer-reviewed journal — discovered that GLP-1 medication might enhance testosterone ranges and sperm high quality in some males with weight problems.
Whereas the findings add to rising curiosity within the relationship between metabolic well being, weight administration, and reproductive operate, the research authors advise warning and word that additional analysis is critical to research this affiliation.
In a proof-of-concept research, researchers from the College of Colorado Anschutz Medical Campus evaluated a subset of contributors enrolled within the ongoing RESTORE scientific trial.
The RESTORE study is investigating whether or not semaglutide or metformin can assist restore ovulation and enhance reproductive well being in adolescents and adults with PMOS and weight problems.
PMOS is a standard endocrine and metabolic situation
“Raised physique mass index (BMI) reduces fertility by inflicting hormonal imbalances, which may disrupt ovulation in ladies,” Clare Thompson, MBBS, BSc, nMRCGP, Normal Practitioner on the Cadogan Clinic, the place she leads the Weight Administration Service, who was not concerned within the research, defined to Medical Information Right now.
“Extra fatty tissue produces oestrogen, which adjustments the pure hormone stability required for normal menstrual cycles and egg launch. The next BMI may also alter the fluid surrounding creating eggs, affecting their high quality and skill to be fertilised by sperm,” Thompson defined.
“Lastly, a better BMI adjustments the uterine lining which may make it tougher for an embryo to connect and due to this fact will increase the chance of miscarriage,” she added.
“GLP-1 drugs can assist a affected person to drop some pounds safely which may kick begin their fertility by regulating the hormone stability once more which can trigger common ovulation to happen, leading to an elevated probability of being pregnant,” Thompson noetd.
Nonetheless, “there are a lot of different causes a feminine could also be chubby aside from easy life-style selections, similar to PMOS, which primarily reduces fertility by disrupting ovulation,” she additional defined.
“It describes a state of affairs the place the hormone imbalance causes a relative rise in androgens (male hormones) alongside insulin resistance, which stalls egg growth. With out common ovulation it turns into tough to conceive and predict when a lady’s fertile window is for copy. Some PMOS sufferers additionally expertise decrease egg high quality and viability and even points with their uterine lining, which may make implantation tougher.”
– Clare Thompson, MBBS, BSc, nMRCGP
The evaluation targeted on contributors ages 12 to 35 years who achieved at the least 10% weight reduction whereas receiving injectable semaglutide.
Investigators reported that enhancements in reproductive markers appeared sooner than anticipated, prompting the publication of preliminary findings earlier than completion of the bigger research.
In accordance with the researchers, the findings counsel that semaglutide might probably handle each features of the situation concurrently, by bettering metabolic well being whereas additionally supporting reproductive operate.
Nonetheless, the research authors emphasised that the present evaluation is preliminary and concerned solely a subset of contributors. The RESTORE trial is ongoing, and longer-term information will probably be vital to find out whether or not the noticed reproductive advantages are sustained.
“The researchers concluded that substantial weight reduction throughout semaglutide remedy was linked to appreciable enhancements in reproductive well being amongst ladies with PMOS and weight problems,” Thompson highlighted.
“The outcomes counsel that addressing extra weight and the underlying metabolic dysfunction related to PMOS can assist restore hormonal stability and enhance reproductive operate. The findings ship early proof that semaglutide might provide a twin profit, concentrating on weight problems and key reproductive challenges related to the situation, together with irregular menstruation and impaired fertility.”
– Clare Thompson, MBBS, BSc, nMRCGP
Individually, a evaluate of 5 randomized managed trials introduced at ENDO 2026 discovered that GLP-1 medication, similar to semaglutide and liraglutide, don’t seem to hurt male fertility and should even enhance testosterone ranges and sperm high quality in some males with weight problems.
“The connection between weight problems, metabolic well being, and fertility has been effectively established for a few years,” Philip Werthman, MD, board-certified urologist, males’s well being specialist, and director of the Heart for Male Reproductive Medication and Vasectomy Reversal in Los Angeles, CA, who was not concerned within the research, instructed MNT.
“In each women and men, weight problems can disrupt regular reproductive hormone signaling, impair fertility, and negatively have an effect on reproductive outcomes. In males, we generally see decrease testosterone ranges, purposeful hypogonadism, erectile dysfunction, and poorer semen parameters,” Werthman defined.
Researchers from the College Hospitals Coventry and Warwickshire and Warwick Medical College in the UK carried out a evaluate of trials analyzing GLP-1 drugs in males ages 18 to 65 years, evaluating GLP-1 therapies with placebo or different remedies.
Throughout the research, GLP-1 medication confirmed no proof of negatively affecting testosterone ranges, reproductive hormones, sexual operate, or sperm high quality.
Notably, a 24-week semaglutide trial reported enhancements in sperm morphology and levels of cholesterol whereas sustaining steady hormone ranges. One other 16-week research discovered that liraglutide elevated testosterone and associated reproductive hormones in males with obesity-related low testosterone.
The researchers word that well being outcomes in these males have been superior to these achieved by way of testosterone alternative remedy alone.
This means a possible shift from testosterone alternative in males with weight problems and low testosterone, as an alternative treating extra weight and metabolic well being, which can restore hormone ranges and protect fertility.
“The male fertility information are additionally turning into more and more compelling,” Werthman added. “Weight problems-related hypogonadism is among the commonest reversible causes of low testosterone that I see in observe. A number of research have demonstrated enhancements in testosterone ranges and sure semen parameters following remedy with GLP-1 receptor agonists.”
“Reviews involving liraglutide have proven enhancements in sperm focus, motility, morphology, and testosterone ranges. Newer semaglutide information counsel enhancements in sperm morphology and testosterone whereas preserving regular gonadotropin signaling.”
– Philip Werthman, MD
“Probably the most essential scientific distinctions is that GLP-1 therapies seem essentially totally different from testosterone alternative remedy for males who want to protect fertility,” he famous.
“Exogenous testosterone can suppress sperm manufacturing by shutting down the hypothalamic-pituitary-gonadal axis. In distinction, GLP-1 receptor agonists enhance metabolic well being and should enhance endogenous testosterone manufacturing with out impairing spermatogenesis,” Werthman defined.
Whereas the precise mechanism is just not absolutely understood, researchers counsel the reproductive advantages from GLP-1 medication could also be pushed by enhancements in metabolic well being.
Weight problems is thought to have an effect on hormone regulation, ovulation, sperm manufacturing, and total reproductive operate. Weight reduction can assist restore hormonal stability and enhance fertility outcomes in each men and women.
GLP-1 medication can enhance blood sugar regulation, cut back urge for food, and infrequently produce substantial weight reduction. These metabolic enhancements might not directly help reproductive well being by decreasing irritation, bettering insulin sensitivity, and restoring hormone manufacturing.
In these with PMOS, insulin resistance is a major contributor to hormonal imbalances and ovulatory dysfunction. Addressing these underlying metabolic issues might assist restore common ovulation and enhance fertility.
“The proof means that weight reduction is the first driver of the reproductive enhancements seen with semaglutide, as substantial weight discount is thought to enhance hormone stability, ovarian operate and fertility in ladies with PMOS.”
– Clare Thompson, MBBS, BSc, nMRCGP
“Nonetheless, GLP-1 medication might also have direct results on reproductive well being by way of mechanisms similar to insulin signalling and ovarian operate. Additional research are wanted to find out how a lot of the profit comes from weight reduction versus the medicine itself,” Thompson famous.
Equally, obesity-related low testosterone is often linked to metabolic dysfunction fairly than main testicular illness. Because of this weight discount might assist restore pure hormone manufacturing.
“As a male fertility specialist, I view these findings as extremely encouraging,” Werthman emphasised. “The broader advantages of GLP-1 remedy—together with enhancements in physique composition, insulin resistance, cardiovascular threat elements, sleep apnea, and total metabolic well being—can all positively affect reproductive operate.”
“As a result of infertility, weight problems, metabolic syndrome, and low testosterone ceaselessly coexist, treating the underlying metabolic illness might have substantial downstream reproductive advantages. Total, I imagine many of the fertility advantages noticed with GLP-1 therapies are presently finest defined by weight reduction and metabolic enchancment,” he instructed us.
“Nonetheless, the consistency of rising information in each women and men raises the likelihood that these drugs might finally show to have direct reproductive results as effectively. Bigger potential research particularly designed to guage fertility outcomes will probably be wanted to reply that query definitively,” Werthman added.
Regardless of the encouraging findings, each analysis groups emphasize that the proof stays preliminary.
The semaglutide research in females represents an early proof-of-concept evaluation from the RESTORE scientific trial, whereas the male fertility findings have been primarily based on a comparatively small variety of research with various methodologies.
Whereas the findings are promising, neither semaglutide nor different GLP-1 receptor agonists have been permitted particularly as fertility remedies.
Future research might study whether or not these reproductive enhancements translate into greater being pregnant charges, improved stay delivery outcomes, and long-term reproductive advantages.
For now, the findings present early proof that the fertility dialog surrounding GLP-1 drugs could also be extra nuanced than beforehand thought.

:max_bytes(150000):strip_icc()/Health-GettyImages-1095286268-75a2277099774949bcd6229023883100.jpg?w=160&resize=160,100&ssl=1)




:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)





Recent Comments